日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Escherichia coli 30S ribosomal protein S15 (rpsO) CSB-YP633392EGW
CSB-EP633392EGW
CSB-BP633392EGW
CSB-MP633392EGW
CSB-EP633392EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli 5-keto-4-deoxy-D-glucarate aldolase (garL) CSB-YP633393EGW
CSB-EP633393EGW
CSB-BP633393EGW
CSB-MP633393EGW
CSB-EP633393EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli L-tartrate/succinate antiporter (ttdT), partial CSB-YP633394EGW
CSB-EP633394EGW
CSB-BP633394EGW
CSB-MP633394EGW
CSB-EP633394EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli tRNA (guanine-N (7)-)-methyltransferase (trmB) CSB-YP633395EGW
CSB-EP633395EGW
CSB-BP633395EGW
CSB-MP633395EGW
CSB-EP633395EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Cell division protein ZapA (zapA) CSB-YP633396EGW
CSB-EP633396EGW
CSB-BP633396EGW
CSB-MP633396EGW
CSB-EP633396EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Bifunctional protein aas (aas), partial CSB-YP633397EGW1
CSB-EP633397EGW1
CSB-BP633397EGW1
CSB-MP633397EGW1
CSB-EP633397EGW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Thymidylate synthase (thyA) CSB-YP633398EGW
CSB-EP633398EGW
CSB-BP633398EGW
CSB-MP633398EGW
CSB-EP633398EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Sulfite reductase [NADPH] flavoprotein alpha-component (cysJ) CSB-YP633399EGW
CSB-EP633399EGW
CSB-BP633399EGW
CSB-MP633399EGW
CSB-EP633399EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli tRNA pseudouridine synthase D (truD) CSB-YP633400EGW
CSB-EP633400EGW
CSB-BP633400EGW
CSB-MP633400EGW
CSB-EP633400EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Regulatory protein recX (recX) CSB-YP633401EGW
CSB-EP633401EGW
CSB-BP633401EGW
CSB-MP633401EGW
CSB-EP633401EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli SsrA-binding protein (smpB) CSB-YP633402EGW
CSB-EP633402EGW
CSB-BP633402EGW
CSB-MP633402EGW
CSB-EP633402EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Elongation factor 4 (lepA) CSB-YP633403EGW
CSB-EP633403EGW
CSB-BP633403EGW
CSB-MP633403EGW
CSB-EP633403EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Serine hydroxymethyltransferase (glyA) CSB-YP633404EGW
CSB-EP633404EGW
CSB-BP633404EGW
CSB-MP633404EGW
CSB-EP633404EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (ispG) CSB-YP633405EGW
CSB-EP633405EGW
CSB-BP633405EGW
CSB-MP633405EGW
CSB-EP633405EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli GDP-mannose pyrophosphatase nudK (nudK) CSB-YP633406EGW
CSB-EP633406EGW
CSB-BP633406EGW
CSB-MP633406EGW
CSB-EP633406EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Cell division protein ZipA homolog (zipA), partial CSB-YP633407EGW
CSB-EP633407EGW
CSB-BP633407EGW
CSB-MP633407EGW
CSB-EP633407EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Response regulator inhibitor for tor operon (torI) CSB-YP633408EGW
CSB-EP633408EGW
CSB-BP633408EGW
CSB-MP633408EGW
CSB-EP633408EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC (mnmC) CSB-YP633409EGW
CSB-EP633409EGW
CSB-BP633409EGW
CSB-MP633409EGW
CSB-EP633409EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli NADH-quinone oxidoreductase subunit C/D (nuoC) CSB-YP633410EGW
CSB-EP633410EGW
CSB-BP633410EGW
CSB-MP633410EGW
CSB-EP633410EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli o-succinylbenzoate synthase (menC) CSB-YP633411EGW
CSB-EP633411EGW
CSB-BP633411EGW
CSB-MP633411EGW
CSB-EP633411EGW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×